Press release
Global Glycomic Therapeutics Market: Immense Growth Expected by 2029 Fueled by Rising Chronic Diseases and Advances in Drug Research
"Focus Broadens on Glycomic Therapeutics: Market to Grow at a 17.4% CAGR from 2025 to 2029
What Is The Projected Market Size Of The Global Glycomic Therapeutics Market And Its Growth Rate?
The global glycomic therapeutics market is projected to exhibit significant growth:
• The market size stood at $164.71 billion in 2024
• It is expected to reach $190.03 billion in 2025, growing at a CAGR of 15.4%.
• Forecasted growth to $361.09 billion by 2029 at a CAGR of 17.4% is anticipated.
• This growth can be attributed to increased understanding of glycan biology, advancements in precision medicine, and a surge in immunotherapy interest.
What Is Driving The Growth In The Glycomic Therapeutics Market?
The increase in the prevalence of diabetes is a significant factor propelling the growth of the glycomic therapeutics market. Diabetes, a chronic medical condition that affects the body's ability to regulate blood sugar levels, witnesses alterations in glycans which potentially contribute to insulin resistance and other metabolic abnormalities. Specific glycan patterns serve as biomarkers for diagnosing diabetes, predicting its progress, and monitoring treatment responses. According to IDF Diabetes Atlas, the global prevalence of diabetes is predicted to rise from 643 million in 2030 to 783 million by 2045. This increase in diabetes cases is consequently driving the growth of the glycomic therapeutics market.
Request A Free Sample Copy:
https://www.thebusinessresearchcompany.com/sample.aspx?id=11894&type=smp
Who Are the Key Players Driving Glycomic Therapeutics Market Growth?
• F Hoffmann-La Roche Ltd.
• Bayer AG
• Sanofi SA
• Thermo Fisher Scientific Inc.
• GlaxoSmithKline plc
• Merck KGaA
• ICON plc
• Agilent Technologies Inc.
• AMS Bio
• Shimadzu Corporation
• Waters Corporation
• Bruker Corporation
• BioMarin Pharmaceutical Inc.
• Bio Techne Corp
• Promega Corporation
• Halozyme Therapeutics Inc.
• Takara Bio Inc.
• Vector Laboratories
• New England Biolabs Inc.
• Protalix Biotherapeutics Inc.
• Genovis AB
• Ray Biotech Life Inc.
• IEC Group
• Ludger Ltd
• Z Biotech LLC
• Alzheon Inc.
• GlycoMar Limited
What Are The Key Trends In The Glycomic Therapeutics Market?
• Expansion of glycomic applications in oncology
• Glycoengineering for enhanced therapeutic proteins
• Inclusion of glycomics in immuno-oncology
• Glycomics in rare and genetic disorders
• Regulatory considerations for glycomic drugs
What Are The Segments Of The Global Glycomic Therapeutics Market?
The global glycomic therapeutics market is segmented by:
• Class: Isolated, Synthetic
• Structures: Glycoproteins, Targeting Sialic Acid, Proteoglycans, Targeting Glycosaminoglycans, Glycosylphosphatidylinositol (GPI)-Anchored Proteins And Heparin Based Glycans, Targeting Glycosphingolipids, Other Structures
• Mode Of Action: Inhibits Neuraminidase, Inhibits Heparanase And Selectins And Blocks Interactions Between Growth Factors And Heparan Sulfate, Erythropoietin And Enzyme Replacement Therapy (ERT), Tissue Plasminogen Activator, Inhibits Glucosylceramide Synthase, Interleukin 1,2 And 3, Beta And Gamma Interferons, Other Mode Of Action
• Indications: Thrombosis And Chemoprophylaxis, Anemia, Anti-Adhesive And Anti-Inflammatory, Cataracts, Gaucher's Disease, MPS-1 And IV, Cancer, Alzheimer's Disease, Influenza Type A and B, Other Indications
Which Region Leads The Glycomic Therapeutics Market?
North America was the largest region in the glycomic therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the coming years. The report covers various regions including Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa for a comprehensive grasp of the global market.
Pre-book the Report for Swift Delivery:
https://www.thebusinessresearchcompany.com/report/glycomic-therapeutics-global-market-report
What Is Covered In The Glycomic Therapeutics Market Global Market Report?
- Market Size Analysis: Analyze the Glycomic Therapeutics Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Glycomic Therapeutics Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Glycomic Therapeutics Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Glycomic Therapeutics Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Request Customization for This Report:
https://www.thebusinessresearchcompany.com/customise?id=11894&type=smp
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead. Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Glycomic Therapeutics Market: Immense Growth Expected by 2029 Fueled by Rising Chronic Diseases and Advances in Drug Research here
News-ID: 3833587 • Views: …
More Releases from The Business research company

Company Registration Service Market Landscape 2025: Forecast Data and Growth Str …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Company Registration Service Market Through 2025?
The market size for company registration services has seen robust growth in the recent past. The market is projected to expand from $10.67 billion in 2024 to $11.55 billion in 2025, exhibiting a compound annual growth…

Comprehensive 2025 Commercial Toilet Partition Market Overview: Trends, Forecast …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Toilet Partition Market Through 2025?
In recent years, the market size for commercial toilet partitions has significantly expanded. The forecast predicts a rise from $1.82 billion in 2024 to $1.95 billion in 2025, with a compound annual growth rate (CAGR) of…

Key Trends Influencing the Growth of the Commercial Insurance For Small And Medi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Insurance For Small And Medium-Sized Enterprises (SMEs) Market Through 2025?
The market size of commercial insurance for small and medium-sized enterprises (SMEs) has seen substantial growth over the recent years. A rise from $111.83 billion in 2024 to $119.76 billion in…

Growing Focus On Reducing Greenhouse Gas Emissions Driving The Market Growth Due …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Combustion Emissions Analyzer Market Through 2025?
In the past few years, the market size for combustion emissions analyzer has seen robust growth. It is projected to increase from $1.02 billion in 2024 to $1.09 billion in 2025, with a compound annual growth…
More Releases for Glycomic
Rising Diabetes Prevalence Fuels Growth In The Glycomic Therapeutics Market: A S …
The Glycomic Therapeutics Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Glycomic Therapeutics Market Size and Projected Growth Rate?
In recent times, the market size for glycomic therapeutics has experienced swift expansion. It is projected to escalate from $164.71 billion in 2024 to…
Primary Catalyst Driving Glycomic Therapeutics Market Evolution in 2025: Rising …
What market dynamics are playing a key role in accelerating the growth of the glycomic therapeutics market?
The anticipated rise in diabetes cases is predicted to propel the expansion of the glycomic therapeutics market. Diabetes, a long-lasting health condition, impairs the body's capacity to regulate blood sugar or glucose levels. Notably, changes in glycans have been identified in diabetes, which possibly contribute to insulin resistance and additional metabolic irregularities. Particular patterns…
Glycomic Therapeutics Market Analysis till 2028 - Scope of The Report
The global glycomic therapeutics market is expected to grow from US$ 99,021.46 million in 2021 to US$ 257,578.79 million in 2028; it is estimated to grow with a CAGR of 15.8% from 2022 to 2028. The report highlights prevailing trends and factors driving the market growth.
The demand for glycomic therapeutics is attributed to a wide application of glycan-based drugs followed by the development of new treatment processes, increasing research and…
Glycomic Therapeutics Market Insights, Demand, and Forecast to 2033
"The new report published by The Business Research Company, titled Glycomic Therapeutics Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033, delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.
As per the report, the glycomic therapeutics market size has grown rapidly in recent years. It will grow from $141.31 billion in…
Glycomic Therapeutics Market: Advancements, Opportunities, and Growth Potential
Market Overview:
Glycomic therapeutics involves the development and utilization of glycan-based drugs or therapies to target specific molecular interactions and pathways in the human body. Glycans play critical roles in cell communication, immune responses, and disease progression, making them attractive targets for therapeutic interventions. The market encompasses various applications, including cancer therapeutics, infectious disease therapeutics, and personalized medicine.
Market Size and Growth:
The Glycomic Therapeutics Market is experiencing significant growth, driven…
Glycomic Therapeutics Market Comprehensive Analysis and Future Estimations by 20 …
The global Glycomic Therapeutics Market is expected to grow from US$ 99,021.46 million in 2021 to US$ 257,578.79 million in 2028; it is estimated to grow with a CAGR of 15.8% from 2022 to 2028.
The report highlights prevailing trends and factors driving the market growth.
The demand for glycomic therapeutics is attributed to a wide application of glycan-based drugs followed by the development of new treatment processes, increasing research and development…